Counterfeit Drugs on NYT Op-Ed Page
One of my old cases is on the op-ed page of today’s New York Times, dealing with 16 year old Timothy Fagan who had an emergency liver transplant and was then injected with counterfeit Epogen. Those drugs had followed a tortured route that included storage in a cooler in the back of a Florida strip club.
The piece is authored by
Katherine Eban, who wrote the book
Dangerous Doses that had profiled how this 2002 incident had occurred.
Tim Fagan’s Law, introduced by
Rep. Steve Israel and designed to better safeguard our drug distribution system, is still pending.
Related posts:
- Counterfeit Drugs: How the election helps consumers
- Counterfeit Drugs and the American Enterprise Institute
- Counterfeit Drugs and Push for RFID In FedTech Magazine
- Counterfeit Drugs Update
- Counterfeit Drugs and Their Deadly Consequences
Tags:
The New York
Personal Injury Law Blog is sponsored by its creator, Eric Turkewitz of The
Turkewitz Law Firm. The blog might be considered a form of attorney advertising
in accordance with New York rules going into effect February 1, 2007 (22 NYCRR
1200.1, et. seq.) As of July 14, 2008, Law.com became an advertiser, as you
can see in the sidebar. Law.com does not control the editorial content of the
blog in any way.
Throughout the
blog as it develops, you may see examples of cases we have handled, or cases
from others, that are used for illustrative purposes. Since all cases are different,
and legal authority may change from year to year, it is important to remember
that prior results in any particular case do not guarantee or predict similar
outcomes with respect to any future matter, including yours, in which any lawyer
or law firm may be retained.
Some of the
commentary may be become outdated. Some might be a minority opinion, or simply
wrong. No reader should consider this site (or any other) to be authoritative,
and if a legal issue is presented, the reader should contact an attorney of
his or her own choosing for advice.
Finally, we
are not responsible for the comments of others that may be added to this site.
No Responses Leave a comment